scholarly article | Q13442814 |
P356 | DOI | 10.1002/CNCR.11562 |
P698 | PubMed publication ID | 12910525 |
P2093 | author name string | Henry T Lynch | |
Teresa A Brentnall | |||
Melissa A Austin | |||
Stephen J Rulyak | |||
P2860 | cites work | Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations | Q57250780 |
Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion ofp16 (p16-Leiden) | Q57948729 | ||
Screening for CDKN2A mutations in hereditary melanoma | Q73378729 | ||
High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families | Q74098963 | ||
A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34 | Q24613943 | ||
Cancer statistics, 2002 | Q28216788 | ||
A cell cycle regulator potentially involved in genesis of many tumor types | Q28251933 | ||
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma | Q28300339 | ||
Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group | Q28307042 | ||
Familial atypical multiple mole-melanoma (FAMMM) syndrome: segregation analysis. | Q33670822 | ||
Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis | Q34378109 | ||
Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome | Q34520664 | ||
Increased risk of cancer in the Peutz-Jeghers syndrome | Q34690977 | ||
Inherited pancreatic cancer: surveillance and treatment strategies for affected families | Q34743083 | ||
CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations | Q35753196 | ||
Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study | Q35992339 | ||
Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds | Q43409626 | ||
Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients | Q44314670 | ||
CDKN2A germline mutations in familial pancreatic cancer | Q44761150 | ||
The Risk of Cancer among Patients with Cystic Fibrosis | Q56779992 | ||
Genotype-Phenotype Relationships in U.S. Melanoma-Prone Families With CDKN2A and CDK4 Mutations | Q57250736 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | phenotype | Q104053 |
P304 | page(s) | 798-804 | |
P577 | publication date | 2003-08-01 | |
P1433 | published in | Cancer | Q326041 |
P1476 | title | Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome | |
P478 | volume | 98 |
Q53518668 | A family history of pancreatic cancer. |
Q35761693 | Clinical germline genetic testing for melanoma. |
Q44828378 | Effect of a detailed family history of melanoma on risk for other tumors: a cohort study based on the nationwide Swedish Family-Cancer Database |
Q61804952 | Familial Melanoma: Diagnostic and Management Implications |
Q38393052 | Familial atypical multiple mole melanoma syndrome in an adult Indian male-case report and literature review |
Q38613449 | Germline variation at CDKN2A and associations with nevus phenotypes among members of melanoma families. |
Q36599686 | Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome |
Q37211362 | Malignant melanoma in the 21st century: the emerging molecular landscape |
Q36233596 | Management strategies for patients with hereditary pancreatic cancer |
Q37641784 | Molecular markers of tumor progression in melanoma |
Q83001745 | Novel presentation of a familial pancreatic cancer syndrome |
Q34986178 | Novel targeted therapies for the treatment of metastatic melanoma |
Q43581873 | Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families |
Q33916380 | Risk factors for pancreatic adenocarcinoma and prospects for screening. |
Q35840024 | Selection criteria for genetic assessment of patients with familial melanoma |
Q81529058 | [Prophylactic pancreas surgery] |